Changes in Plasma Glucose, Insulin, Glucagon, Catecholamine, and Glycogen Contents in Tissues during Development of Alloxan Diabetes Mellitus in Rats

Oi, 1990, Anabolic response in the renal cortex of diabetic rats: Synthetase of glycogen, J Med Soc Toho, 37, 42

Oi, 1990, Determination of low content glycogen in kidney cortex of diabetes rats, J Anal BioSci, 13, 38

Dunn, 1943, Necrosis of the islets of Langerhans produced experimentally, Lancet, 1, 484

Houssay, 1945, The mechanism of action of alloxan on blood sugar, Science, 102, 197, 10.1126/science.102.2643.197

Lukens, 1948, Alloxan diabetes, Physiol Rev, 28, 304, 10.1152/physrev.1948.28.3.304

Wrenshall, 1950, Initial changes in the blood sugar of the fasted anesthetized dog after alloxan, Am J Physiol, 160, 228, 10.1152/ajplegacy.1950.160.2.228

Kosaka, 1954, Studies on the mechanism of alloxan initial hyperglycemia: The role of pituitary and adrenal glands in connection with the effect of alloxan on the blood sugar, Tohoku J Exp Med, 59, 379, 10.1620/tjem.59.379

Kikuchi, 1968, Changes in plasma immunoreactive insulin level during the development of alloxan diabetes in dogs, J Jpn Diabetes Soc, 11, 351

Tasaka, 1988, Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog, Endocrinol Jpn, 35, 399, 10.1507/endocrj1954.35.399

Gorray, 1983, Cytotoxic effects of alloxan treatment in vitro on monolayer cultures of neonatal rat pancreas, Am J Physiol, 245, E417

Douglas, 1992, Increased rate of gluconeogenesis in type 2 diabetes mellitus, J Clin Invest, 90, 1323, 10.1172/JCI115997

Yamamoto, 1981, Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets, Nature, 294, 284, 10.1038/294284a0

Turner, 1990, Insulin use in NIDDM—Rationale based on pathophysiology of disease, Diabetes Care, 13, 1011, 10.2337/diacare.13.9.1011